Ret Proto-Oncogene Protein (RET) (AA 29-273) (His tag)
-
- Target See all Ret Proto-Oncogene (RET) Proteins
- Ret Proto-Oncogene (RET)
- Protein Type
- Recombinant
- Protein Characteristics
- AA 29-273
- Origin
- Mouse
-
Source
- Escherichia coli (E. coli)
- Purification tag / Conjugate
- This Ret Proto-Oncogene protein is labelled with His tag.
- Application
- Western Blotting (WB), Immunogen (Imm), Positive Control (PC), SDS-PAGE (SDS)
- Sequence
- Leu29-Phe273
- Characteristics
- Recombinant Ret Proto-Oncogene (RET), Prokaryotic expression, Leu29-Phe273, N-terminal His Tag
- Purity
- > 90 %
- Top Product
- Discover our top product RET Protein
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Isoelectric Point:5.4
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-80 °C
- Storage Comment
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Expiry Date
- 12 months
-
- Target
- Ret Proto-Oncogene (RET)
- Alternative Name
- Ret Proto-Oncogene (RET Products)
- Synonyms
- c-ret Protein, cret Protein, etID315074.13 Protein, ret1 Protein, wu:fd13h01 Protein, X-ret Protein, ret-A Protein, xret Protein, RET Protein, MTC1 Protein, CDHF12 Protein, CDHR16 Protein, HSCR1 Protein, MEN2A Protein, MEN2B Protein, PTC Protein, RET-ELE1 Protein, RET51 Protein, RET9 Protein, c-Ret Protein, ret proto-oncogene receptor tyrosine kinase Protein, ret proto-oncogene S homeolog Protein, ret proto-oncogene Protein, ret Protein, ret.S Protein, RET Protein, Ret Protein
- Background
- CDHR16, CRet, PTC, CDHF12, HSCR1, MEN2A, MEN2B, MTC1, RET-ELE1, RET51, C-Ret, Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Cadherin-Related 16
- Molecular Weight
- 32kDa
- UniProt
- P35546
- Pathways
- RTK Signaling, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
-